Ott Mariliis, Jing Lichen, Lorenzo Lazaro, Casanova Jean-Laurent, Zhang Shen-Ying, Koelle David M
From the *Department of Medicine, University of Washington, Seattle, Washington; †Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, University Paris Descartes, Imagine Institute, Paris 75015, France; ‡St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York; §Department of Laboratory Medicine, University of Washington, ¶Department of Global Health, University of Washington, ‖Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, and **Benaroya Research Institute, Seattle, Washington.
Pediatr Infect Dis J. 2017 Aug;36(8):741-744. doi: 10.1097/INF.0000000000001631.
Herpes simplex encephalitis (HSE) after primary herpes simplex virus (HSV)-1 infection can occur in children due to inborn errors of cell-intrinsic immunity in the central nervous system. Paradoxically, symptomatic mucocutaneous HSV-1 recurrences are rare survivors of childhood HSE. T-cell-acquired immunity is thought to be involved in control of recurrent mucocutaneous HSV infection. We thus tested HSV-1-specific immunity in HSE survivors.
We obtained serum and peripheral blood mononuclear cells (PBMCs) from participants a median of 13.5 years after HSE. HSV-1 and HSV-2 IgG was detected by type-specific immunoblot. PBMCs from subjects passing quality control criteria were tested using enzyme-linked immunospot assay for CD4 interferon-γ responses with an HSV-1 lysate and for CD8 responses using pooled synthetic HSV-1 peptide CD8 T-cell epitopes. Healthy adult PBMCs were used to standardize assays and as comparators.
All participants were HSV-1 seropositive. Most (23/24) HSE survivors had human leukocyte antigen class I types matching the human leukocyte antigen restriction of the pooled peptides. We detected HSV-specific CD8 T-cell responses in 14 of 24 (58%) HSE survivors and in 9 of 9 healthy HSV-1 seropositive adults. HSV-specific CD4 T-cell responses were present in all 5 HSE subjects tested and in 8 of 9 healthy adults. Response magnitudes were overlapping between subject groups.
The defects in cell-intrinsic immunity leading to failure to control primary central nervous system HSV-1 infection do not preclude the acquisition of specific immunity or the control of recurrent mucocutaneous HSV infections. The rarity and lack of severe or recurrent mucocutaneous HSV infection in survivors of childhood HSE corresponds with intact adaptive T-cell immunity.
原发性单纯疱疹病毒(HSV)-1感染后的单纯疱疹性脑炎(HSE)可发生于儿童,这是由于中枢神经系统中细胞固有免疫的先天性缺陷所致。矛盾的是,有症状的黏膜皮肤HSV-1复发在儿童HSE幸存者中很少见。T细胞获得性免疫被认为参与了复发性黏膜皮肤HSV感染的控制。因此,我们检测了HSE幸存者的HSV-1特异性免疫。
我们在HSE发生后中位数13.5年从参与者中获取血清和外周血单核细胞(PBMC)。通过型特异性免疫印迹法检测HSV-1和HSV-2 IgG。对通过质量控制标准的受试者的PBMC,使用酶联免疫斑点试验检测其对HSV-1裂解物的CD4干扰素-γ反应以及使用合成HSV-1肽CD8 T细胞表位池检测CD8反应。使用健康成人PBMC标准化检测并作为对照。
所有参与者HSV-1血清学检测均为阳性。大多数(23/24)HSE幸存者的人类白细胞抗原I类类型与合成肽池的人类白细胞抗原限制相匹配。我们在24名HSE幸存者中的14名(58%)以及9名健康的HSV-1血清学阳性成年人中的9名检测到了HSV特异性CD8 T细胞反应。在所有检测的5名HSE受试者以及9名健康成年人中的8名中存在HSV特异性CD4 T细胞反应。各受试者组之间的反应强度有重叠。
导致无法控制原发性中枢神经系统HSV-1感染的细胞固有免疫缺陷并不排除获得特异性免疫或控制复发性黏膜皮肤HSV感染。儿童HSE幸存者中黏膜皮肤HSV感染罕见且无严重或复发现象,这与适应性T细胞免疫完整相一致。